Human immune system is ‘ready to go’ long before birth

(Press-News.org) By creating the first spatial atlas of the developing human thymus, a vital organ that trains immune cells to protect against infections and cancer, scientists have discovered that the foundation for lifelong immunity is established earlier than previously thought.

Researchers from the Wellcome Sanger Institute and their collaborators at Ghent University, Belgium, the National Institutes of Health’s National Institute of Allergy and Infectious Diseases and others, uncovered key differences in the development of immune cells. This understanding could help scientists engineer immune cells outside the body to fight cancer, counter age-related immune decline, or prevent transplant rejection risks.

The study, published today (20 November) in Nature, is part of the international Human Cell Atlas (HCA) initiative to map every cell type in the human body1. Insights gained from studying how thymus samples change before and after birth could help future researchers generate an artificial thymus, the first step in being able to engineer therapeutic immune cells for older adults or people with compromised immune systems.

This paper is one of a collection of more than 40 HCA publications in Nature Portfolio journals that represent a milestone leap in our understanding of the human body.

The immune system protects the body from infections and cancer with the help of a diverse array of T cells, a type of white blood cell. T cells must first be trained to recognise threats without attacking the body’s own healthy cells. The thymus, a small organ behind the breastbone, is where this crucial T cell training occurs.

When the thymus malfunctions, it can result in weakened immunity or autoimmune diseases, where the body mistakenly attacks itself, leading to conditions such as type 1 diabetes or rheumatoid arthritis.

Despite its importance, little is known about the early development of the thymus, as it uniquely functions primarily during infancy and then gradually degenerates over the lifespan2. Studying its early stages could allow us to understand why immunity wanes with age, leaving older adults vulnerable to infection and less responsive to vaccines3.

In this new study, researchers from the Wellcome Sanger Institute and their collaborators tracked thymus and T cell development in samples ranging from eleven weeks post-conception to three years old4 using single cell sequencing and advanced spatial mapping techniques.

They discovered that the organ’s basic structure and function is established as early as twelve weeks post-conception, suggesting that early pregnancy factors may have a more profound impact on lifelong immune function than previously recognised.

The team uncovered key differences in the development of various T cells types5 — some that help orchestrate immune responses by directing other immune cells and others that directly attack infected or cancerous cells. This understanding could inform new T cell engineering therapies that selectively boost immunity for cancer treatments or suppress it for autoimmune conditions and transplants.

The researchers also discovered locations of progenitor cells that give rise to important supporting cells in the thymus which also mimic the body’s own environment so that T cells would not react to self. This could help researchers in the future to create an artificial thymus for regenerative immune therapies for older adults or people with compromised immune systems.

A key achievement of the study was the creation of a standardised high resolution spatial mapping method called OrganAxis to compare the composition and structural organisation of thymus samples across various stages of development at a much higher resolution than ever before. This approach could be applied to other organs that change significantly over time or vary widely across individuals, such as the liver or kidneys.

Dr Nadav Yayon, co-first author of the study formerly at the Wellcome Sanger Institute and EMBL-EBI, and now based at the Cambridge Stem Cell Institute, University of Cambridge, said: “The thymus is uniquely crucial in setting up lifelong immunity, but until now, comparing its different developmental stages was almost impossible, as they appeared like completely different organs. OrganAxis lets us integrate different spatial datasets to uncover hidden properties that go unnoticed when viewed individually. Using key structures as reference points, much like a hiker uses landmarks to navigate, we now see how structures are formed early on, enabling us to track T cell training over time.”

Dr Veronika Kedlian, co-first author of the study formerly at the Wellcome Sanger Institute, and now based at the Cambridge Stem Cell Institute, University of Cambridge, said: “Our atlas of healthy thymus development could lead to new strategies for boosting immunity, particularly in older adults or those with thymus deficiencies. We are already applying this resource to study age-related immune changes and conditions like DiGeorge syndrome, where children are born without a functioning thymus and are highly vulnerable to infections.”

Dr Sarah Teichmann, senior author of the study and co-founder of the Human Cell Atlas, formerly at the Wellcome Sanger Institute, and now based at the Cambridge Stem Cell Institute, University of Cambridge, said: “This thymus map is the first full model of a human organ at single cell resolution and transcriptomic breadth. It represents a crucial piece of the puzzle in our effort to understand human biology cell by cell in the Human Cell Atlas. By understanding how the thymus educates immune cells from their earliest stages, we are opening up insights into immune deficiencies and autoimmune conditions. The map offers an important perspective for developing therapies to strengthen or correct immune responses.”

ENDS

Contact details:
Rachael Smith

Press Office
Wellcome Sanger Institute
Cambridge, CB10 1SA
Email: press.office@sanger.ac.uk

Notes to Editors:

Supporting images can be found here.

The freely available developing human thymus spatial data can be explored through a web portal here: https://cellxgene.cziscience.com/collections/fc19ae6c-d7c1-4dce-b703-62c5d52061b4

 

This study is part of the international Human Cell Atlas (HCA) consortium, which is creating comprehensive reference maps of all human cells as a basis for both understanding human health and diagnosing, monitoring, and treating disease. The HCA is an international collaborative consortium whose mission is to create comprehensive reference maps of all human cells—the fundamental units of life—as a basis for understanding human health and for diagnosing, monitoring, and treating disease. The HCA community is producing high-quality Atlases of tissues, organs and systems, to create a milestone Atlas of the human body. More than 3,500 HCA members from over 100 countries are working together to achieve a diverse and accessible Atlas to benefit humanity across the world.  Discoveries are already informing medical applications from diagnoses to drug discovery, and the Human Cell Atlas will impact every aspect of biology and healthcare, ultimately leading to a new era of precision medicine. https://www.humancellatlas.org
  The thymus is very unique in its development and activity. Children born without a functioning thymus lack T cells and are extremely vulnerable to infections, for example those with severe immune deficiencies such as SCID, but those who have a healthy thymus removed in order to gain access to the heart during surgery retain a functioning immune system. This shows that the thymus plays an essential role particularly early in life, training T cells and setting up lifelong immunity. During the thymus ageing process, the T cell growth areas in the thymus are replaced with fatty tissue, diminishing T cell production and contributing to a dampened immune system.
  C. Kellogg (2020) ‘The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization’ Human Vaccines & Immunotherapeutics. DOI: 10.1080/21645515.2020.1818519
  Thymus samples were provided by the University of Newcastle, National Institutes of Health, and Ghent University, Belgium.
  In the thymus, special cells help train developing T cells, which are crucial for our immune system. Some cells in the thymus mimic our body’s own cells, teaching T cells what is ‘normal’ and what is not and others act as gatekeepers, checking that T cells have completed this training and are ready to move on. This is essential — if these cells fail to present the right signals and T cells do not learn correctly, the immune system can mistakenly attack healthy tissues, leading to autoimmune diseases. These cells act as ‘teachers’ in the thymus, presenting a diverse array of self-proteins to developing T cells. One important discovery in the study was that T cells destined to become CD8 cells —known for killing infected or cancerous cells — stay in the thymus's cortex longer before moving to the next stage of development compared to CD4 cells, which help regulate immune responses. Publication:
N. Yayon et al. (2024) ‘A spatial human thymus cell atlas mapped to a continuous tissue axis.’ Nature. DOI: 10.1038/s41586-024-07944-6

Funding:
This research was supported by Wellcome and the Chan Zuckerberg Initiative. For full funding acknowledgements, please refer to the publication.

Selected websites:

Ghent University

Ghent University is one of the major universities in the Dutch-speaking region of Europe. It distinguishes itself as a socially committed and pluralistic university in a broad international perspective. 86 faculty departments, spread over 11 faculties, offer high-quality courses in every one of their scientific disciplines. With a view to cooperation in research and community service, numerous research groups, centres and institutes have been founded over the years. https://www.ugent.be/en

The Cambridge Stem Cell Institute (CSCI) is a world-leading centre for stem cell research with a mission to transform human health through a deep understanding of normal and pathological stem cell behaviour.  Bringing together biological, clinical and physical scientists operating across a range of tissue types and at multiple scales, we explore the commonalities and differences in stem cell biology in a cohesive and inter-disciplinary manner. Located on a purpose-built facility on the Cambridge Biomedical Campus and housing over 350 researchers, including a critical mass of clinician scientists, the Institute integrates with neighbouring disease-focused research institutes and also serves as a hub for the wider stem cell community in Cambridge. www.stemcells.cam.ac.uk

The Wellcome Sanger Institute

The Wellcome Sanger Institute is a world leader in genomics research. We apply and explore genomic technologies at scale to advance understanding of biology and improve health. Making discoveries not easily made elsewhere, our research delivers insights across health, disease, evolution and pathogen biology. We are open and collaborative; our data, results, tools, technologies and training are freely shared across the globe to advance science.

Funded by Wellcome, we have the freedom to think long-term and push the boundaries of genomics. We take on the challenges of applying our research to the real world, where we aim to bring benefit to people and society.

Find out more at www.sanger.ac.uk or follow us on Twitter, Instagram, Facebook, LinkedIn and on our Blog.

About Wellcome
Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges: mental health, infectious disease and climate and health. https://wellcome.org/

END